Statement from the Growth Hormone Research Society来自生长激素研究协会的声明.pptVIP

Statement from the Growth Hormone Research Society Keswick Hall Charlottesville, Virginia May 7 - 10, 2000 Critical Evaluation of the Safety of Recombinant Human Growth Hormone Administration Background Epidemiological and experimental data used to assess relationships of GH, IGF-I and cancer risk Safety aspects GH therapy in children GH replacement in adults Pharmacological GH treatment in adults Closing remarks Participants Robert Baxter Bengt ?ke Bengtsson Sandra L. Blethen Werner F. Blum Bjorn Carlsson Lena Carlsson Paul V. Carroll Jens Sandahl Christiansen Peter E. Clayton David R. Clemmo